376 related articles for article (PubMed ID: 33729478)
1. ALS/FTD-causing mutation in cyclin F causes the dysregulation of SFPQ.
Rayner SL; Cheng F; Hogan AL; Grima N; Yang S; Ke YD; Au CG; Morsch M; De Luca A; Davidson JM; Molloy MP; Shi B; Ittner LM; Blair I; Chung RS; Lee A
Hum Mol Genet; 2021 May; 30(11):971-984. PubMed ID: 33729478
[TBL] [Abstract][Full Text] [Related]
2. Pathogenic mutation in the ALS/FTD gene, CCNF, causes elevated Lys48-linked ubiquitylation and defective autophagy.
Lee A; Rayner SL; Gwee SSL; De Luca A; Shahheydari H; Sundaramoorthy V; Ragagnin A; Morsch M; Radford R; Galper J; Freckleton S; Shi B; Walker AK; Don EK; Cole NJ; Yang S; Williams KL; Yerbury JJ; Blair IP; Atkin JD; Molloy MP; Chung RS
Cell Mol Life Sci; 2018 Jan; 75(2):335-354. PubMed ID: 28852778
[TBL] [Abstract][Full Text] [Related]
3. TDP-43 is a ubiquitylation substrate of the SCF
Rayner SL; Yang S; Farrawell NE; Jagaraj CJ; Cheng F; Davidson JM; Luu L; Redondo AG; Rábano A; Borrego-Hernández D; Atkin JD; Morsch M; Blair IP; Yerbury JJ; Chung R; Lee A
Neurobiol Dis; 2022 Jun; 167():105673. PubMed ID: 35231559
[TBL] [Abstract][Full Text] [Related]
4. TDP-43 pathology and functional deficits in wild-type and ALS/FTD mutant cyclin F mouse models.
van Hummel A; Sabale M; Przybyla M; van der Hoven J; Chan G; Feiten AF; Chung RS; Ittner LM; Ke YD
Neuropathol Appl Neurobiol; 2023 Apr; 49(2):e12902. PubMed ID: 36951214
[TBL] [Abstract][Full Text] [Related]
5. The E3 Ubiquitin Ligase SCF Cyclin F Promotes Sequestosome-1/p62 Insolubility and Foci Formation and is Dysregulated in ALS and FTD Pathogenesis.
Davidson JM; Wu SSL; Rayner SL; Cheng F; Duncan K; Russo C; Newbery M; Ding K; Scherer NM; Balez R; García-Redondo A; Rábano A; Rosa-Fernandes L; Ooi L; Williams KL; Morsch M; Blair IP; Di Ieva A; Yang S; Chung RS; Lee A
Mol Neurobiol; 2023 Sep; 60(9):5034-5054. PubMed ID: 37243816
[TBL] [Abstract][Full Text] [Related]
6. Cyclin F, Neurodegeneration, and the Pathogenesis of ALS/FTD.
Rayner SL; Hogan A; Davidson JM; Cheng F; Luu L; Morsch M; Blair I; Chung R; Lee A
Neuroscientist; 2024 Apr; 30(2):214-228. PubMed ID: 36062310
[TBL] [Abstract][Full Text] [Related]
7. CCNF mutations in amyotrophic lateral sclerosis and frontotemporal dementia.
Williams KL; Topp S; Yang S; Smith B; Fifita JA; Warraich ST; Zhang KY; Farrawell N; Vance C; Hu X; Chesi A; Leblond CS; Lee A; Rayner SL; Sundaramoorthy V; Dobson-Stone C; Molloy MP; van Blitterswijk M; Dickson DW; Petersen RC; Graff-Radford NR; Boeve BF; Murray ME; Pottier C; Don E; Winnick C; McCann EP; Hogan A; Daoud H; Levert A; Dion PA; Mitsui J; Ishiura H; Takahashi Y; Goto J; Kost J; Gellera C; Gkazi AS; Miller J; Stockton J; Brooks WS; Boundy K; Polak M; Muñoz-Blanco JL; Esteban-Pérez J; Rábano A; Hardiman O; Morrison KE; Ticozzi N; Silani V; de Belleroche J; Glass JD; Kwok JB; Guillemin GJ; Chung RS; Tsuji S; Brown RH; García-Redondo A; Rademakers R; Landers JE; Gitler AD; Rouleau GA; Cole NJ; Yerbury JJ; Atkin JD; Shaw CE; Nicholson GA; Blair IP
Nat Commun; 2016 Apr; 7():11253. PubMed ID: 27080313
[TBL] [Abstract][Full Text] [Related]
8. ALS-linked CCNF variant disrupts motor neuron ubiquitin homeostasis.
Farrawell NE; Bax M; McAlary L; McKenna J; Maksour S; Do-Ha D; Rayner SL; Blair IP; Chung RS; Yerbury JJ; Ooi L; Saunders DN
Hum Mol Genet; 2023 Jul; 32(14):2386-2398. PubMed ID: 37220877
[TBL] [Abstract][Full Text] [Related]
9. A proteomic network approach across the ALS-FTD disease spectrum resolves clinical phenotypes and genetic vulnerability in human brain.
Umoh ME; Dammer EB; Dai J; Duong DM; Lah JJ; Levey AI; Gearing M; Glass JD; Seyfried NT
EMBO Mol Med; 2018 Jan; 10(1):48-62. PubMed ID: 29191947
[TBL] [Abstract][Full Text] [Related]
10. ALS/FTD-associated mutation in cyclin F inhibits ER-Golgi trafficking, inducing ER stress, ERAD and Golgi fragmentation.
Ragagnin AMG; Sundaramoorthy V; Farzana F; Gautam S; Saravanabavan S; Takalloo Z; Mehta P; Do-Ha D; Parakh S; Shadfar S; Hunter J; Vidal M; Jagaraj CJ; Brocardo M; Konopka A; Yang S; Rayner SL; Williams KL; Blair IP; Chung RS; Lee A; Ooi L; Atkin JD
Sci Rep; 2023 Nov; 13(1):20467. PubMed ID: 37993492
[TBL] [Abstract][Full Text] [Related]
11. Casein kinase II phosphorylation of cyclin F at serine 621 regulates the Lys48-ubiquitylation E3 ligase activity of the SCF
Lee A; Rayner SL; De Luca A; Gwee SSL; Morsch M; Sundaramoorthy V; Shahheydari H; Ragagnin A; Shi B; Yang S; Williams KL; Don EK; Walker AK; Zhang KY; Yerbury JJ; Cole NJ; Atkin JD; Blair IP; Molloy MP; Chung RS
Open Biol; 2017 Oct; 7(10):. PubMed ID: 29021214
[TBL] [Abstract][Full Text] [Related]
12. Mutations of CCNF gene is rare in patients with amyotrophic lateral sclerosis and frontotemporal dementia from Mainland China.
Pan C; Jiao B; Xiao T; Hou L; Zhang W; Liu X; Xu J; Tang B; Shen L
Amyotroph Lateral Scler Frontotemporal Degener; 2017 May; 18(3-4):265-268. PubMed ID: 28281833
[TBL] [Abstract][Full Text] [Related]
13. Common Molecular Pathways in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.
Weishaupt JH; Hyman T; Dikic I
Trends Mol Med; 2016 Sep; 22(9):769-783. PubMed ID: 27498188
[TBL] [Abstract][Full Text] [Related]
14. The emerging roles of microRNAs in the pathogenesis of frontotemporal dementia-amyotrophic lateral sclerosis (FTD-ALS) spectrum disorders.
Gascon E; Gao FB
J Neurogenet; 2014; 28(1-2):30-40. PubMed ID: 24506814
[TBL] [Abstract][Full Text] [Related]
15. Expression of ALS/FTD-linked mutant CCNF in zebrafish leads to increased cell death in the spinal cord and an aberrant motor phenotype.
Hogan AL; Don EK; Rayner SL; Lee A; Laird AS; Watchon M; Winnick C; Tarr IS; Morsch M; Fifita JA; Gwee SSL; Formella I; Hortle E; Yuan KC; Molloy MP; Williams KL; Nicholson GA; Chung RS; Blair IP; Cole NJ
Hum Mol Genet; 2017 Jul; 26(14):2616-2626. PubMed ID: 28444311
[TBL] [Abstract][Full Text] [Related]
16. Splicing factor proline and glutamine rich intron retention, reduced expression and aggregate formation are pathological features of amyotrophic lateral sclerosis.
Hogan AL; Grima N; Fifita JA; McCann EP; Heng B; Fat SCM; Wu S; Maharjan R; Cain AK; Henden L; Rayner S; Tarr I; Zhang KY; Zhao Q; Zhang ZH; Wright A; Lee A; Morsch M; Yang S; Williams KL; Blair IP
Neuropathol Appl Neurobiol; 2021 Dec; 47(7):990-1003. PubMed ID: 34288034
[TBL] [Abstract][Full Text] [Related]
17. ALS and FTD: Where RNA metabolism meets protein quality control.
Mandrioli J; Mediani L; Alberti S; Carra S
Semin Cell Dev Biol; 2020 Mar; 99():183-192. PubMed ID: 31254610
[TBL] [Abstract][Full Text] [Related]
18. Synaptic dysfunction and altered excitability in C9ORF72 ALS/FTD.
Starr A; Sattler R
Brain Res; 2018 Aug; 1693(Pt A):98-108. PubMed ID: 29453960
[TBL] [Abstract][Full Text] [Related]
19. Familial ALS-associated
Widagdo J; Udagedara S; Bhembre N; Tan JZA; Neureiter L; Huang J; Anggono V; Lee M
Open Biol; 2022 Sep; 12(9):220187. PubMed ID: 36168806
[TBL] [Abstract][Full Text] [Related]
20. Distribution of ubiquilin 2 and TDP-43 aggregates throughout the CNS in UBQLN2 p.T487I-linked amyotrophic lateral sclerosis and frontotemporal dementia.
Nementzik LR; Thumbadoo KM; Murray HC; Gordon D; Yang S; Blair IP; Turner C; Faull RLM; Curtis MA; McLean C; Nicholson GA; Swanson MEV; Scotter EL
Brain Pathol; 2024 May; 34(3):e13230. PubMed ID: 38115557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
